Jane Street’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-106
Closed -$10K 9553
2023
Q1
$10K Sell
106
-469
-82% -$44.7K ﹤0.01% 8735
2022
Q4
$56K Sell
575
-818
-59% -$119K ﹤0.01% 8325
2022
Q3
$359K Buy
+1,393
New +$405K ﹤0.01% 7289
2022
Q1
Sell
-136
Closed -$22K 11012
2021
Q4
$22K Sell
136
-140
-51% -$30.8K ﹤0.01% 9776
2021
Q3
$75K Buy
276
+99
+56% +$30.3K ﹤0.01% 9402
2021
Q2
$70K Sell
177
-202
-53% -$94.3K ﹤0.01% 9407
2021
Q1
$205K Buy
+379
New +$236K ﹤0.01% 8232
2020
Q3
Sell
-127
Closed -$63K 7895
2020
Q2
$63K Buy
+127
New +$56.6K ﹤0.01% 6822
2020
Q1
Sell
-90
Closed -$64K 5962
2019
Q4
$64K Sell
90
-338
-79% -$233K ﹤0.01% 4887
2019
Q3
$275K Buy
+428
New +$340K ﹤0.01% 4268
2018
Q2
Sell
-127
Closed -$75K 5608
2018
Q1
$75K Buy
+127
New +$79.1K ﹤0.01% 4642
2017
Q3
Sell
-677
Closed -$632K 5049
2017
Q2
$632K Buy
677
+595
+726% +$583K ﹤0.01% 2723
2017
Q1
$78K Sell
82
-562
-87% -$523K ﹤0.01% 3991
2016
Q4
$517K Buy
644
+569
+759% +$513K ﹤0.01% 2831
2016
Q3
$63K Sell
75
-18
-19% -$14.5K ﹤0.01% 3885
2016
Q2
$76K Sell
93
-198
-68% -$216K ﹤0.01% 3923
2016
Q1
$324K Sell
291
-248
-46% -$254K ﹤0.01% 3117
2015
Q4
$671K Buy
539
+359
+199% +$594K ﹤0.01% 2165
2015
Q3
$243K Buy
+180
New +$297K ﹤0.01% 2991
2015
Q2
Sell
-243
Closed -$392K 4029
2015
Q1
$392K Buy
+243
New +$360K ﹤0.01% 2279

Other funds holding TCRT

Jane Street's TCRT Position: Q4 2023 in Review

Jane Street sold out of Alaunos Therapeutics (TCRT) in Q4 2023, closing a stake of 84 shares — an estimated $1.67K sold.

Jane Street first reported a position in TCRT in Q2 2013 and held it in 30 quarters. The position peaked at $1.51M in Q2 2015. 82 funds tracked by Wall St. Rank hold TCRT as of Q4 2023.

  • Jane Street reported no remaining Alaunos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Jane Street sold 84 Alaunos Therapeutics shares in Q4 2023, an estimated $1.67K.
  • Jane Street first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 30 quarters.
  • Jane Street's Alaunos Therapeutics position peaked at $1.51M in Q2 2015.
  • 82 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2023.

Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.